{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027883",
    "licUnit": "1",
    "validDate": "2025-05-15 00:00:00.000",
    "issueDate": "2020-05-15 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202788304",
    "prodNameC": "利伐沙班",
    "prodNameE": "Rivaroxaban",
    "indicationsName": [
        "抗凝血劑"
    ],
    "does": "0042",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "44"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "55CAE78F-A909-4138-A594-E8E1D9C14B64",
    "subCategory": [],
    "ingredientsDesc": [
        "Rivaroxaban (modification-I) contains not less than 98.5% and not more than 101.5% of C19H18ClN3O5S, calculated on the anhydrous basis."
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "鴻傑藥品有限公司",
    "applicantAddr": "台北市中山區南京東路2段206號10樓之3",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "0FBD02DB-9A90-4ED9-A58B-3838C8DEDE4B",
            "factoryCode": "1",
            "factoryName": "COHANCE LIFESCIENCES LIMITED",
            "factoryAddr": "PLOT NO. 3102\/B, GIDC ESTATE ANKLESHWAR, BHARUCH - 393002, GUJARAT, INDIA",
            "factoryCompanyAddr": null,
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN1263000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Rivaroxaban (modification-I) contains not less than 98.5% and not more than 101.5% of C19H18ClN3O5S, calculated on the anhydrous basis.",
            "ingredientsDesc": "Rivaroxaban (modification-I) contains not less than 98.5% and not more than 101.5% of C19H18ClN3O5S, calculated on the anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "B2D4B2A2-220C-4DB0-8E56-6B1962BBD48D"
}